title: PARP inhibitors and IR join forces to strike glioblastoma-initiating cells.
authors.affiliation: 1] National Centre of Competence in Research Frontiers in Genetics, Geneva, Switzerland [2] Department of Molecular Biology, University of Geneva, Geneva, Switzerland.
authors.forename: N
authors.initials: N
authors.lastname: Lugli
authors.affiliation: Department of Molecular Biology, University of Geneva, Geneva, Switzerland.
authors.forename: I
authors.initials: I
authors.lastname: Kamileri
authors.affiliation: 1] Department of Molecular Biology, University of Geneva, Geneva, Switzerland [2] Department of Biochemistry, University of Geneva, Geneva, Switzerland.
authors.forename: T D
authors.initials: TD
authors.lastname: Halazonetis
mesh_terms: D000818:Animals; D005909:Glioblastoma / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D008297:Male; D014411:Neoplastic Stem Cells / Q000378:metabolism* / Q000473:pathology*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism*
chemical_list: D011065:Poly(ADP-ribose) Polymerases